| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 13 |
| 1 | GABAPENTIN | 13 |
| 2 | ACETAMINOPHEN | 12 |
| 3 | ACETAMINOPHEN 500MG | 12 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 12 |
| 5 | OFATUMUMAB | 12 |
| 6 | PAIN RELIEVER | 12 |
| 7 | BENDAMUSTINE HCL | 5 |
| 8 | PREDNISONE | 5 |
| 9 | PREGABALIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACOMITINIB | 1 | 0.0013 |
| 1 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 3 | OFATUMUMAB | 12 | 0.0004 |
| 4 | BARICITINIB | 1 | 0.0003 |
| 5 | BENDAMUSTINE HCL | 5 | 0.0003 |
| 6 | BOTULINUM TOXIN TYPE A | 4 | 0.0003 |
| 7 | MINOCYCLINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 1 | 0.0001 |
| 9 | METHYLPREDNISOLONE ACETATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Acetylcholine Release Inhibitor [EPC] | 6 | 0.0001 |
| 2 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 17 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Fluoroquinolone Antibacterial [EPC] | 3 | 0.0000 |
| 7 | Anti-IgE [EPC] | 2 | 0.0000 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |